Am J Gastroenterol 2023 Sep 1
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.
Related Questions
New answer by Medical Oncologist at The Ohio State University School of Medicine (March 4, 2025)
The short answer is yes, while also sending the patient to hepatology for HCV treatment. If the patient has minimal disease burden and systemic therapy can be delayed, one sma...